Skip to main content
Subscribe
Register
Sign in
Membership
Events
Knowledge Center
About
Subscribe
Register
Sign in
Hedge Funds
Latest Articles
Premium
D1 Capital Leads Tiger Crowd as Hedge Fund Returns Diverge in August
Stephen Taub
September 15, 2025
Premium
Biopharma Hedge Funds Rebounded Sharply Last Month — But Is It Sustainable?
Stephen Taub
September 11, 2025
Premium
August Surge Offers Relief to Managed Futures Funds — But Not Redemption
Stephen Taub
September 10, 2025
Will Ackman Finally Cash In on His Fannie Mae and Freddie Mac ‘Lottery Ticket?’
Michelle Celarier
September 9, 2025
Premium
Valiant’s Summer Slump
Stephen Taub
September 9, 2025
Premium
Third Point Falls Behind as August Loss Wipes Out the Year’s Gains
Stephen Taub
September 8, 2025
Premium
Einhorn’s Greenlight Misses the Rally, Again
Stephen Taub
September 2, 2025
Premium
In a Brutal Year for CTAs, One Fund Breaks Away
Stephen Taub
August 21, 2025
Premium
Chris Hansen’s Bet on Power Sparks Big Gains
Stephen Taub
August 20, 2025
Druckenmiller’s Equity Bets Hit Seven-Year Peak
Stephen Taub
August 18, 2025
Premium
Prominent Funds Bought the Nvidia Dip — Now It’s Paying Off
Stephen Taub
August 18, 2025
Premium
Biopharma Funds Deliver Rare Monthly Gains
Stephen Taub
August 14, 2025
Premium
Discovery Extends Multiyear Run With Strong July, Now Up 17.5% in 2025
Stephen Taub
August 12, 2025
Dan Loeb’s Third Point Outpaces S&P in July, Adds Two New Positions
Stephen Taub
August 6, 2025
Premium
Hedge Fund VC Activity Reveals Biopharma’s Fading Momentum
Stephen Taub
August 5, 2025
William Heard’s Decision to Shutter His Long-Short Fund Pays Off
Stephen Taub
July 31, 2025
Premium
Viking’s Private Equity Funds Moved Into the Black in Q2
Stephen Taub
July 30, 2025
Premium
Dorsal Is Back in the Black
Stephen Taub
July 29, 2025
More Articles